[1] 王艳梅. 活血化瘀中药注射剂药品不良反应临床研究[J].世界最新医学信息文摘(连续型电子期刊)2020,20(69),326-327. [2] 薛伟新,黄庆嘉,陈炜.丁苯酞注射液联合丹红注射液治疗急性脑梗死的临床疗效及对氧化应激指标,血管内皮生长因子水平的影响[J].中西医结合心脑血管病杂志,2020,18(15):4. [3] 李海涛,崔文强,王育霞,等.丹参类中药注射液辅助治疗急性缺血性脑卒中临床效果的网状系统评价[J].山东医药,2023,63(11):54-58. [4] 吴苏果,彭雪,阳伟红,等.《神农本草经》与经方应用之大枣篇[J].山东中医药大学学报,2025,49(02):189-195. [5] 刘丽萍,周宏宇,段婉莹,等.中国脑血管病临床管理指南(第2版)(节选)——第4章缺血性脑血管病临床管理推荐意见[J].中国卒中杂志,2023,18(8):910-933. [6] 刘塞兵,代晓杰,樊同,等.探究胞二磷胆碱针剂联合丹红注射液治疗脑后循环缺血性眩晕患者的临床疗效[J].临床和实验医学杂志,2022(008):021. [7] 张磊,刘建民.美国国立卫生研究院卒中量表[J].中华神经外科杂志,2014. [8] 《中国脑卒中防治报告2021》编写组,王陇德.《中国脑卒中防治报告2021》概要[J].中国脑血管病杂志,2023,20(11):783-792. [9] 夏晋蜀,邢俊生.丁苯酞注射液联合丹红注射液对急性缺血缺氧性脑损伤的临床治疗研究[J].中国药物与临床,2020,20(21):3589-3590. [10] Lin YK,Chen YJ,Li JY,et al.Salvianolic acid A from Danhong Injection induces vasorelaxation by Regulating L-type calcium channel in isolated mouse arteries[J].J Ethnopharmacol,2022,296:115431. [11] Qi Y,Zou Y,Chen L,et al.Pharmacological Mechanisms Underlying the Therapeutic Effects of Danhong Injection on Cerebral Ischemia[J].Evid Based Complement Alternat Med,2021,2021:5584809. [12] 刘海超,孔勇,王培福.丹红注射液用于老年缺血性脑血管病治疗的临床效果观察[J].中文科技期刊数据库(全文版)医药卫生,2024(003):001. [13] Jiang X,Chen Y,Zhu H,et al.Sodium Tanshinone IIA Sulfonate Ameliorates Bladder Fibrosis in a Rat Model of Partial Bladder Outlet Obstruction by Inhibiting the TGF-β/Smad Pathway Activation[J].PLoS One,2015,10(6):e0129655. [14] Guo S,Wu J,Zhou W,et al.Investigating the multi-target pharmacological mechanism of danhong injection acting on unstable angina by combined network pharmacology and molecular docking[J].BMC Complement Med Ther,2020,20(1):66. [15] Zhang MY,Guo FF,Wu HW,et al.DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy[J].Oncotarget,2017,8(61):103393-103409. [16] Zhang W,Li J,Yang P,et al.Efficacy and Safety of Salvia miltiorrhiza for Treating Chronic Kidney Diseases:A Systematic Review and Meta-Analysis[J].Evid Based Complement Alternat Med,2022,2022:2117433. [17] Liu HH,Wei W,Wu FF,et al.Sodium tanshinone IIA sulfonate protects vascular relaxation in ApoE-knockout mice by inhibiting the SYK-NLRP3 inflammasome-MMP2/9 pathway[J].BMC Cardiovasc Disord,2024,24(1):354. [18] 中华人民共和国国家卫生健康委员会.脑血管病防治指南(2024年版)[J].磁共振成像,2025,16(01):1-8. [19] Lopes CS,Curty J,Carvalho FA,et al.A mathematical model of fibrinogen-mediated erythrocyte-erythrocyte adhesion[J].Commun Biol,2023,6(1):192. [20] 杨志华,毕颖斐,毛静远,等.基于网络药理学探讨清痰化瘀方治疗冠心病痰热瘀结证的作用机制[J].中西医结合心脑血管病杂志,2022,20(1):28-36. [21] Chen J,Shang J,Liu H,et al.Comparative effectiveness and safety of four traditional Chinese medicine injections with invigorating blood circulation,equivalent effect of anticoagulation or antiplatelet in acute myocardial infarc-tion:a Bayesian network meta-analysis[J].Front Pharmacol,2024,15:1400990. [22] Hu T,Zou HX,Le SY,et al.Tanshinone IIA confers pro-tection against myocardial ischemia/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1[J].Int J Mol Med,2023,52(5):109. [23] Li L,Yang JH,Li C,et al.Danhong injection improves neurological function in rats with ischemic stroke by enhancing neurogenesis and activating BDNF/AKT/CREB signaling pathway[J].Biomed Pharmacother,2023,163:114887. [24] Theriot J,Wermuth HR,Ashurst JV.Antiemetics,Selective 5-HT3 Antagonists[J].In:StatPearls.Treasure Island(FL):StatPearls Publishing,April 19,2024. [25] Yang S,Wang Y,Shen H,et al.Efficacy and safety of Danhong injection for treating myocardial infarction:a systematic review and meta-analysis of randomized controlled trials[J].Front Pharmacol,2024,15:1371959.
2025, Vol. 45 
